Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 4, 2026 · Leadership change · Item 5.07 · Financial statements
| ItemItem | Disclosure |
|---|---|
| Item 5.02 | Director or executive officer departure or appointment |
| Item 5.07 | Item 5.07 |
| Item 9.01 | Financial statements and exhibits |
Kura Oncology, Inc. filed this to disclose a change in directors or executive officers appointments, departures, or role changes that can signal a strategic shift.
Amended and Restated 2014 Equity Incentive Plan Amended and Restated by the Board: March 6, 2015 Approved by the Stockholders: March 6, 2015 Amended by the Board: September 26, 2022 and April 4, 2023 Approved by the Stockholders: May 31, 2023 Amended by the Board: April 7, 2024 Approved by the Stockholders: June 5, 2024 Amended by the Board: April 8, 2025 Approved by the Stockholders: June 5, 2025 Amended by the Board: April 9, 2026 Approved by the Stockholders: June 4, 2026 1. Employees, Directors and Consultants…
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Kura Oncology, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
